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All NOD.H-2h4 mice develop spontaneous 
autoimmune thyroiditis (SAT) when given NaI 
in their drinking water (1–3). Thyroid infl  am-
mation is chronic, with infi  ltration of thyroids 
by lymphocytes, including CD4+ and CD8+ T 
cells, and B220+ B cells (3–6). All mice that 
develop SAT produce anti–mouse thyroglobu-
lin (MTg)-specifi  c autoantibodies, and IgG1 
and IgG2b autoantibody levels generally cor-
relate with SAT severity scores (1, 5). We pre-
viously showed that B cell–defi  cient NOD.
H-2h4 mice did not develop SAT (5). Although 
adult B cell–defi  cient mice reconstituted with 
B cells or given passive anti-MTg autoanti-
bodies did not develop SAT, T cells from B 
cell–defi  cient mice could function as eff  ector 
cells if B cells were provided during the matu-
ration of T cells from bone marrow precursors 
(5). These results suggested that B cells were 
required for the early activation of CD4+ T 
cells, functioning either as important APCs 
for activation of CD4+ eff  ector T cells or to 
amplify responses of eff  ector T cells so they 
could manifest their pathogenic potential. Be-
cause the defect in adult B cell–defi  cient mice 
could not be corrected by reconstitution of B 
cells or anti-MTg autoantibodies (5), we hy-
pothesized that CD4+ eff  ector T cells initially 
activated in the absence of B cells might be ren-
dered unresponsive so they were unable to in-
duce SAT when B cells were provided to adults. 
Unresponsiveness of eff  ector T cells could be 
due to induction of anergy or to preferential 
activation of regulatory T (T reg) cells when 
autoantigen is initially presented in the absence 
of B cells.
T cells specifi  c for self-antigens not neg-
atively selected in the thymus can be present in 
the periphery at birth (7–9). In some strains of 
mice, nontolerant potentially autoreactive T cells 
can be activated and lead to spontaneous auto-
immune disease. Activation of autoreactive T 
cells requires or is facilitated by B cells in sev-
eral systems (10–20). In most cases,   activation 
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Wild-type (WT) NOD.H-2h4 mice develop spontaneous autoimmune thyroiditis (SAT) when 
given 0.05% NaI in their drinking water, whereas B cell–defi  cient NOD.H-2h4 mice are SAT 
resistant. To test the hypothesis that resistance of B cell–defi  cient mice to SAT was due to 
the activity of regulatory CD4+CD25+ T (T reg) cells activated if autoantigen was initially 
presented on non–B cells, CD25+ T reg cells were transiently depleted in vivo using anti-
CD25. B cell–defi  cient NOD.H-2h4 mice given three weekly injections of anti-CD25 devel-
oped SAT 8 wk after NaI water. Thyroid lesions were similar to those in WT mice except 
there were no B cells in thyroid infi  ltrates. WT and B cell–defi  cient mice had similar num-
bers of CD4+CD25+Foxp3+ cells. Mice with transgenic nitrophenyl-specifi  c B cells unable 
to secrete immunoglobulin were also resistant to SAT, and transient depletion of T reg cells 
resulted in severe SAT with both T and B cells in thyroid infi  ltrates. T reg cells that inhibit 
SAT were eliminated by day 3 thymectomy, indicating they belong to the subset of natu-
rally occurring T reg cells. However, T reg cell depletion did not increase SAT severity in WT 
mice, suggesting that T reg cells may be nonfunctional when effector T cells are activated; 
i.e., by autoantigen-presenting B cells.
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of self-reactive lymphocytes in the periphery is prevented by 
naturally occurring T reg cells, a subset of thymus-derived 
CD4+ T cells that constitutively express CD25 (7–9). Day 3 
thymectomy (Tx) in mice that do not normally develop 
spontaneous autoimmune disease results in development of 
organ-specifi  c autoimmune diseases, including thyroiditis due 
to elimination of CD4+CD25+ T reg cells (21, 22). B cell–
defi  cient NOD.H-2h4 mice might not develop SAT if B 
cells are required for optimal activation of autoreactive T 
cells and if naturally occurring T reg cells are preferentially 
activated if B cells are not available to present autoantigen. 
This study was undertaken to test this hypothesis by asking if 
B cell–defi  cient mice would develop SAT if CD25+ T reg 
cells were transiently eliminated.
RESULTS
CD25+CD4+ T cells are not elevated in B cell–defi  cient mice
To begin to determine if increases in peripheral CD4+CD25+ 
T reg cells might explain the resistance of B cell–defi  cient 
mice to SAT, percentages of CD4+CD25+ T cells were 
compared in the spleens and peripheral blood of 4- and 8-
wk-old B cell–defi  cient and WT mice. Although there was 
some variation, the percentages of CD4+CD25+ T cells were 
similar (averaging 10–15% of CD4+ T cells) for 4–8-wk-old 
WT and B cell–defi  cient mice (Fig. 1, A and B) not given 
NaI water as well as for older mice given NaI water for 
8 wk (not depicted). Although most CD4+CD25+ cells in B 
cell–defi  cient mice could have been T reg cells, while some 
CD4+CD25+ cells in WT mice could have been activated 
CD25+ eff  ector T cells, the two populations could not be 
distinguished by CD25 expression. These results indicate that 
diff  erences in absolute numbers of peripheral CD4+CD25+ 
T cells in naive B cell–defi  cient versus WT mice do not ex-
plain their diff  erent susceptibility to SAT.
SAT develops in B cell–defi  cient mice given anti-CD25 mAb
B cell–defi  cient NOD.H-2h4 mice given NaI water do not 
develop SAT, whereas all WT mice develop SAT and pro-
duce anti-MTg autoantibodies under the same conditions 
(Table I). To determine if the inability of B cell–defi  cient 
Figure 1.  Flow cytometric analysis of CD4+CD25+ splenic T 
cells from 6-wk-old WT (A), B cell–defi  cient (B), and NP Tg (C) 
NOD.H-2h4 mice, CD8+CD25+ splenic T cells from NP Tg (D) mice, 
and CD4+CD25+ splenic T cells from NP Tg mice given anti-CD25 
2 (E) or 7 (F) d previously as analyzed by fl  ow cytometry. Results are 
representative of 5–10 mice analyzed in each group. The percentages of 
CD25+ cells in the gated CD4+ or CD8+ cells are indicated in the top right 
of each panel.
Table I. Development of SAT in B cell–defi  cient NOD.H-2h4 mice given anti-CD25 mAb
Micea SAT severityb Anti-MTgc
0 1 +2 +3 + I g G 1 IgG2B
NOD.H-2h4μnull 5 0 0 0 0.060 ± 0.005 0.003 ± 0.001
μnull (anti-CD25) 0 2 3 0 0.062 ± 0.009 0.001 ± 0.001
NOD.H-2h4 WT  1 2 6 2 0.307 ± 0.071 0.393 ± 0.087
WT (anti-CD25) 5 3 2 0 0.234 ± 0.133 0.355 ± 0.061
Mice in lines 2 and 4 received 0.5 mg anti-CD25 mAb 10, 17, and 24 d after birth. Mice in lines 1 and 3 received normal rat Ig on days 10, 17, and 24.
aFemale NOD.H-2h4WT or B cell–defi  cient (μnull)mice were given 0.05% NaI in their water beginning at 8 wk of age.
bNumbers of mice with various degrees of severity of SAT 8 wk after NaI water. P-values: line 1 versus line 2, P < 0.0002; line 2 versus line 3, P > 0.6; line 3 versus line 4, 
P < 0.01.
cAnti-MTg IgG1 and IgG2B expressed as OD410 ± SEM.JEM VOL. 203, February 20, 2006  351
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mice to develop SAT might be due to CD4+CD25+ T reg 
cells that suppressed the activation or function of eff  ector T 
cells, B cell–defi  cient mice were given three weekly injec-
tions of anti-CD25 mAb beginning at 10 d of age (23). This 
resulted in depletion of most CD4+CD25+ T cells 2–3 d 
  after the last injection of mAb (Fig. 1 E). CD4+CD25+ 
T cells gradually returned, and nearly normal numbers of 
CD4+CD25+ splenic T cells were detected 7–10 d after the 
last antibody injection (Fig. 1 F). B cell–defi  cient mice given 
three weekly injections of anti-CD25 beginning at 10 d of 
age developed SAT, whereas B cell–defi  cient mice given rat 
Ig did not develop SAT (Table I). The SAT severity scores of 
anti-CD25–treated B cell–defi  cient mice were comparable to 
those of rat Ig–treated WT NOD.H-2h4 mice (P > 0.6 for 
the experiment shown in Table I). Thyroid lesions in both 
WT and B cell–defi  cient mice predominantly had lympho-
cyte infi  ltration (Fig. 2, A and B vs. D and E), but all lym-
phocytes in the thyroids of B cell–defi  cient mice were T cells 
(Fig. 3, D–F), whereas many B cells were also present in WT 
thyroids (Fig. 3 B). WT mice given anti-CD25 beginning at 
10 d of age consistently developed less severe SAT than con-
trols (Table I, line 3 vs. line 4; P < 0.01). This may be due to 
elimination of CD25+ eff  ector T cells that could have devel-
oped before anti-CD25 was administered. These results sug-
gest that the inability of B cell–defi  cient mice to develop 
SAT can be explained, at least in part, by the activity of 
CD25+ T reg cells that limit the ability of eff  ector CD4+ T 
cells to expand or become activated. B cell–defi  cient mice 
clearly have CD4+ T cells that can function as eff  ector cells 
for SAT if CD25+ T cells are transiently depleted so their 
T cells are not anergic. Because CD25 depletion is transient, 
the results also suggest that T reg cells do not effi   ciently in-
hibit eff  ector T cells after they have been activated.
Mice with B cells unable to secrete Ig do not develop SAT 
unless they are given anti-CD25
To further examine the mechanisms by which B cells regu-
late development of SAT, we asked if transgenic (Tg) mice 
with nitrophenyl (NP)-specifi  c B cells that cannot secrete Ig 
(12) would develop SAT. The percentage of splenic B220+ 
B cells was similar for WT and NP Tg mice (not depicted), and 
CD4+CD25+ cells in the spleens of NP Tg mice (Fig. 1 C) 
were comparable to those of WT and B cell–defi  cient mice 
(Fig. 1, A and B). Very few CD8+ T cells in the spleens of NP 
Tg (Fig. 1 D), WT, or B cell–defi  cient mice (not depicted) 
Figure 2.  Hematoxylin and eosin–stained thyroids from WT, 
B cell–defi  cient, and NP Tg NOD.H-2h4 mice 2 mo after NaI water. 
(A) WT mouse with 2+ SAT, (B) WT mouse with 4+ SAT, and (C) B cell–
defi  cient mouse given rat Ig; severity score, 0. (D and E) B cell–defi  cient 
mice given anti-CD25; D, 1+; E, 2+. (F) Rat Ig–treated NP Tg mouse; 
severity score, 0. (G–J) NP Tg mice given anti-CD25; G, 2+; H, 3+; I and J, 
4–5+. Magnifi  cation: A–G and J, 100; H and I, 40.
Figure 3.  Immunohistochemical staining for CD4, CD8, and B220 
in WT mice and in B cell–defi  cient and NP Tg mice given anti-CD25 
beginning at 10 d of age as described in Materials and methods. 
All mice were given 0.05% NaI water at 8 wk of age. All infi  ltrating lym-
phocytes in B cell–defi  cient thyroids are CD4 and CD8+ T cells. WT and 
NP Tg thyroids also have many B220+ B cells. Magnifi  cation: 400.352   REGULATORY T CELLS IN B CELL–DEFICIENT MICE | Yu et al.
expressed CD25. Tg mice, like B cell–defi  cient mice, devel-
oped no or very mild SAT after receiving NaI water (Table II), 
produced no detectable serum anti-MTg autoantibodies 
  (Table II), and were serum Ig negative (not depicted). How-
ever, NP Tg mice developed severe SAT (P < 10−9 compared 
with controls), but no detectable anti-MTg autoantibodies, 
after being given anti-CD25 to transiently deplete T reg cells. 
Treatment of NP Tg mice with another rat anti–mouse mAb, 
i.e., anti–IL-10 (Table II), using the injection schedule used 
for anti-CD25 had no eff  ect on SAT. Thyroid lesions in anti-
CD25–treated NP Tg mice were histologically like those in 
WT mice, although severity scores were often higher. Some 
NP Tg mice had very severe thyroid infl  ammation, with pro-
liferation of thyroid epithelial cells (Fig. 2, I and J) and fi  brosis 
(not depicted). Thyroid infi  ltrates in anti-CD25–treated NP 
Tg mice included many B220+ B cells (Fig. 3 H) as well 
as CD4+ and CD8+ T cells (Fig. 3, G and I). The presence 
of B cells in the thyroids of anti-CD25–treated NP Tg mice 
is of interest because their B cells are NP specifi  c (12, 20), do 
not secrete Ig, and presumably do not include specifi  cities for 
thyroid proteins. This suggests that traffi   cking of B cells to the 
thyroid can be independent of specifi  city for thyroid proteins 
and/or secretion of autoantibodies, and production of auto-
antibodies in the thyroid or in the circulation is not necessary 
for optimal thyroid damage.
Depletion of CD25+ T cells does not result in SAT in other 
SAT-resistant NOD.H-2h4 mice
Because B cell–defi  cient and NP Tg mice, both normally re-
sistant to SAT, developed SAT after anti-CD25 treatment, it 
was of interest to determine if other SAT-resistant mice also 
developed SAT after depletion of CD25+ T cells. To address 
this question, IFN-γ–defi  cient mice (24) and WT NOD.H-
2h4 mice that have mutated and do not develop SAT (25) 
were given three weekly injections of anti-CD25 beginning 
at 10 d of age and 0.05% NaI water at 8 wk. Thyroids were 
examined 8 wk later (Table III). Anti-CD25 did not result in 
SAT in these mice, suggesting that their resistance to SAT 
is probably not due to T reg cell activity. More importantly, 
the results indicate that the transient lymphopenia induced by 
CD25 depletion (26–28) is not suffi   cient for development of 
SAT. It is not known why SAT-resistant WT NOD.H-2h4 
mice given anti-CD25 had higher anti-MTg autoantibody 
responses than controls (Table III).
Timing of CD25 depletion is not critical for SAT 
development in B cell–defi  cient or NP Tg mice
Our previous study suggested that B cells were required dur-
ing the fi  rst 4–6 wk after birth for development of SAT in 
WT mice (5). To determine if early CD25 depletion was 
necessary for B cell–defi  cient mice to develop SAT, B cell–
defi  cient and NP Tg mice were given three weekly injec-
tions of anti-CD25 beginning 11 d, 4 wk, or 8 wk after birth 
(Table IV). Mice given anti-CD25 11 d or 4 wk after birth 
all developed SAT with similar severity scores. Because CD25 
depletion is transient (Fig. 1 F), normal numbers of CD25+ 
T cells were present when mice began NaI water. In prelimi-
nary experiments, B cell–defi  cient mice given anti-CD25 beg  -
inning at 8 wk developed minimal SAT (not depicted), and 
NP Tg mice given anti-CD25 beginning at 8 wk developed 
Table II. Development of SAT in NP Tg mice given anti-CD25 mAb
Micea SAT severityb Anti-MTgc
01 + 2+ 3+ 4+ IgG1 IgG2B
NP Tg 9 2 0 0 0 0.060 ± 0.005 0.003 ± 0.001
NP Tg (anti-CD25) 0 0 3 4 4 0.062 ± 0.009 0.001 ± 0.001
NP Tg (anti–IL-10) 4 1 0 0 0 0.010 ± 0.004 0.052 ± 0.053
aFemale NOD.H-2h4 NP Tg μnull mice were given 0.05% NaI water beginning at 8 wk of age. Mice received 0.5 mg anti-CD25 (PC61), anti–IL-10 (JESS 2A5), or normal rat Ig 
10, 17, and 24 d after birth as indicated.
bNumbers of mice with various degrees of severity of SAT 8 wk after NaI water. P-values: line 1 versus line 2, P < 10−9; line 1 versus line 3, P > 0.9.
cAnti-MTg IgG1 and IgG2B expressed as OD410 ± SEM.
Table III. All SAT-resistant NOD.H-2h4 mice do not develop SAT after treatment with anti-CD25 mAb
Micea SAT severityb Anti-MTgc
01 + 2+ 3+ 4+ IgG1 IgG2B
NOD.H-2h4 WT 0 1 2 2 0 0.238 ± 0.096 0.331 ± 0.046
SAT-resistant WT 5 3 2 0 0 0.182 ± 0.074 0.085 ± 0.049
SAT-resistant WT (anti-CD25) 4 2 0 0 0 0.413 ± 0.064 0.386 ± 0.036
IFN-γ−/− NOD.H2h4 4 0 1 0 0 0.218 ± 0.040 0.213 ± 0.031
IFN-γ−/− (anti-CD25) 3 1 0 0 0 0.306 ± 0.079 0.388 ± 0.076
aFemale NOD.H-2h4WT, SAT-resistant WT (reference 25), or IFNγ−/− (reference 24) NOD.H-2h4 mice were given 0.05% NaI water beginning at 8 wk of age. Mice received 
0.5 mg anti-CD25 (PC61) or normal rat Ig 10, 17, and 24 d after birth as indicated.
bNumber of mice with various degrees of severity of SAT 8 wk after NaI water.
cAnti-MTg IgG1 and IgG2B expressed as OD410 ± SEM.JEM VOL. 203, February 20, 2006  353
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less severe SAT than those given anti-CD25 at day 11 (Table 
IV, lines 6 and 7). Because mice all began NaI water at 8 wk 
of age, CD25 depletion was maintained during the fi  rst 3 wk 
when eff  ector T cell activation begins (1). Because activated 
eff  ector CD4+ T cells also express CD25, it was important to 
determine if mice given anti-CD25 beginning at 8 wk of age 
would develop SAT if more time was allowed for optimal 
development of SAT. Therefore, mice given anti-CD25 at 
weeks 8, 9, and 10 were given NaI water at 11 wk of age, 
and thyroids were removed 8 wk later. Most mice developed 
SAT, although the severity scores were slightly lower than in 
mice given anti-CD25 earlier (Table IV, line 4 vs. lines 2 and 
3). These results suggest that if suffi   cient time is allowed for 
SAT development, eff  ector T cell function can be manifest 
even when T reg cells are eliminated in adults.
T reg cells that inhibit SAT in B cell–defi  cient and NP Tg 
mice are eliminated by day 3 Tx
Because naturally occurring T reg cells are eliminated by 
Tx at 3 d of age (21, 22, 29), we asked if day 3 Tx B cell–
  defi  cient and NP Tg mice would develop SAT (7–9, 21, 22, 
30). Groups of WT and Tg mice were thymectomized at 3 d, 
given NaI water at 8 wk, and thyroids were removed 8 wk 
later (Table V). Day 3 Tx had no eff  ect on SAT development 
in WT mice. These results are consistent with those obtained 
using anti-CD25 (Table I) and suggest that T reg cells do not 
inhibit SAT in WT mice. However, most Tx NP Tg (Table V) 
and B cell–defi  cient (not depicted) mice developed SAT, 
  indicating that eff  ector T cells can be activated and/or ex-
panded when T reg cells are eliminated by day 3 Tx. The two 
NP Tg mice in Table V that did not develop SAT had thy-
mic remnants at autopsy and were not lymphopenic. In con-
trast, all Tx WT mice and the six NP Tg mice that developed 
SAT had minimal or no residual thymus and were T cell 
lymphopenic, with a 30–50% reduction in CD4+ and CD8+ 
T cells in peripheral blood and spleen relative to non-Tx 
  littermates and a correspondingly increased percentage of 
B220+ B cells (not depicted).
WT and B cell–defi  cient mice have similar numbers 
of CD4+CD25+Foxp3+ T cells
The results presented so far suggest that CD25+ T reg cells 
may be preferentially activated in SAT-resistant B cell–
  defi  cient and NP Tg NOD.H-2h4 mice, whereas SAT-
susceptible WT mice may have fewer CD25+ T reg cells 
and/or eff  ector CD4+ T cells are preferentially activated 
in WT mice. Foxp3 is expressed by CD4+CD25+ T cells 
with T reg cell function, but not by eff  ector CD4+CD25+ T 
Table IV. SAT in B cell–defi  cient and NP Tg mice given anti-CD25 mAb at various times
Micea SAT severityb
0 1+ 2+ 3+ 4+
Controls (μ- ) 50000
anti-CD25 day 11 (μ- ) 03111
anti-CD25 4 wk (μ- ) 00501
anti-CD25 8 wk 13200
NP-Tg Controls 32100
anti-CD25 day 11 (NP Tg) 00433
anti-CD25 8 wk (NP Tg) 11210
aFemale μnull (lines 1–3) or NP Tg (lines 5–7) mice were given 0.05% NaI water at 8 wk.  Mice in line 4 received NaI water for 8 wk beginning at 10 wk of age to allow for 
recovery of CD25+ cells after the last injection of anti-CD25. Mice in lines 2, 4, 6, and 7 received three weekly injections of 0.5 mg anti-CD25 beginning at the indicated time 
after birth. Mice in lines 1 and 5 received rat Ig.
bNumber of mice with various degrees of severity of SAT 8 wk after NaI water.
Table V. Effect of day 3 Tx on development of SAT in WT and NP Tg mice
Micea SAT severityb Anti-MTgc
01 + 2+ 3+ 4+ IgG1 IgG2B
WT controls  00620 0.007 ± 0.007 0.013 ± 0.005
WT day 3 Txd 10331 0 . 0 1 3   ± 0.008 0.031 ± 0.009
NP Tg controls 51000 0 . 0 2 1   ± 0.010 0.017 ± 0.007
NP Tg day 3 Txd 2e 2400 0 . 0 1 0   ± 0.004 0.052 ± 0.053
aFemale and male WT and NP Tg mice were thymectomized at 3 d of age. Thymectomized and littermate control nonthymectomized mice were given 0.05% NaI water 
beginning at 8 wk of age.
bNumbers of mice with various degrees of severity of SAT 8 wk after NaI water. P-values: line 1 versus line 2, P > 0.5; line 3 versus line 4, P < 0.001, excluding the two 
animals in line 4 with residual thymus.
cAnti-MTg IgG1 and IgG2B expressed as OD410 ± SEM.
dMost thymectomized mice had fewer CD4+ and CD8+ T cells and a correspondingly increased percentage of B220+ B cells in their spleens as determined by fl  ow cytometry.
eMice were not lymphopenic and had residual thymus at autopsy.354   REGULATORY T CELLS IN B CELL–DEFICIENT MICE | Yu et al.
cells (31–34). To determine if diff  erences in the numbers 
of CD4+25+Foxp3+ cells might explain why WT mice are 
  susceptible and B cell–defi  cient mice are resistant to SAT, 
spleen cells from 6–8-wk-old WT and B cell–defi  cient mice 
were separated into CD4+CD25-depleted and CD4+CD25-
enriched populations as described in Materials and methods. 
RNA was isolated and reverse transcribed, and real-time PCR 
for Foxp3 was performed. CD4+CD25+ cells from both WT 
and B cell–defi  cient mice had a much higher expression of 
Foxp3 mRNA than CD25-depleted cells from the same mice 
(Fig. 4 A), and CD25+ T cells in WT and B cell–defi  cient 
mice expressed comparable levels of Foxp3. CD4+ splenic 
T cells from 8-wk-old WT and B cell–defi  cient mice were 
also examined for Foxp3 expression by fl  ow cytometry (Fig. 
4, B–D) and immunohistochemical staining (not depicted). 
These results also indicated that WT and B cell–defi  cient 
mice have similar numbers of CD4+CD25+Foxp3+ T cells 
in spleens (Fig. 4, B–D) and cervical lymph nodes (not de-
picted) at the time they begin NaI water. The percentages 
of CD4+CD25−Foxp3+ cells that may be able to diff  erenti-
ate into CD25+ T reg cells were also similar in the spleens 
of WT and B cell–defi  cient mice (Fig. 4, C and D). Thus, 
diff  erences in the numbers of splenic CD4+CD25+Foxp3+ 
cells do not explain the diff  erent susceptibility of WT and B 
cell–defi  cient mice to SAT.
DISCUSSION
This study was undertaken to test the hypothesis that resis-
tance of B cell–defi  cient NOD.H-2h4 mice to SAT was due 
to naturally occurring T reg cells that inhibited activation 
and/or expansion of SAT eff  ector T cells. The results indi-
cate that transient depletion of CD25+ T cells by anti-CD25 
or depletion of naturally occurring T reg cells by day 3 Tx 
resulted in SAT in B cell–defi  cient mice. These results sug-
gest that SAT eff  ector T cells are not anergic in B cell–defi  -
cient mice, and if T reg cells are depleted, non–B cells can 
function as APCs for activation of these eff  ector T cells.
CD4+CD25+ splenic T cells from B cell–defi  cient, WT 
(Fig. 4 A), and NP Tg mice (not depicted) highly expressed 
mRNA for Foxp3, a marker expressed by CD4+CD25+ T 
cells with regulatory function but not by CD4+CD25+ eff  ec-
tor T cells (31–34). CD4+CD25+ T cells from WT, NP Tg, 
and B cell–defi  cient mice all had similar levels of Foxp3 
mRNA (Fig. 4 A and not depicted). Flow cytometry results 
also indicated that the spleens of WT and B cell–defi  cient 
mice had similar numbers of CD4+CD25+Foxp3+ as well as 
CD4+CD25−Foxp3+ cells (Fig. 4, B–D), suggesting suscep-
tible and resistant mice have comparable numbers of T reg 
cells. At 8 wk of age, when mice are given NaI water, eff  ec-
tor T cells have apparently already expanded in WT mice and 
they develop SAT 8 wk later. In contrast, eff  ector T cells ex-
pand in B cell–defi  cient and NP Tg mice only if T reg cells 
are transiently depleted. These results suggest that antigen-
specifi  c B cells may be needed to optimally present antigen 
to eff  ector T cells in the presence of T reg cells, and even if 
some eff  ector T cells are activated by other APCs, activation 
is suboptimal in comparison to WT mice. Therefore, even 
though all three strains have comparable numbers of T reg cells, 
T reg cell function predominates in mice lacking antigen-
specifi  c B cells, resulting in resistance to SAT.
The results presented here suggest that T reg cells have no 
apparent function in WT mice because depletion of CD25+ 
T cells and day 3 Tx did not increase SAT severity in WT 
mice. This suggests that T reg cells in WT mice may have lost 
their suppressive function as suggested by others (35), or that 
after eff  ector T cells become activated, they cannot be sup-
pressed by T reg cells. The fact that B cell–defi  cient mice 
  develop SAT even though CD25+ T cells are depleted only 
transiently is consistent with the idea that eff  ector T cells may 
be resistant to suppression by T reg cells. Studies are in prog-
ress to directly compare the ability of CD4+CD25+ T cells 
from WT and B cell–defi  cient mice to inhibit T cell re-
sponses in vitro and to inhibit development of SAT in vivo. 
It will also be important to determine if CD4+CD25+ T cells 
from B cell–defi  cient mice can inhibit SAT development in 
WT mice.
Previous studies established a role for B cells in the activa-
tion of autoreactive T cells in several autoimmune diseases. 
These studies suggested that B cells might function as APCs 
Figure 4.  CD4+CD25+ T cells from WT and B cell–defi  cient mice 
express similar amounts of Foxp3. (A) Expression of Foxp3 mRNA by 
CD4+CD25-depleted and CD4+CD25-enriched cells from 6–8-wk-old 
naive WT and B cell–defi  cient NOD.H-2h4 mice. There was no signifi  cant 
difference in expression of Foxp3 by CD25+ cells from WT and B cell–
defi  cient mice (P > 0.3). (B) Spleen cells from WT and B cell–defi  cient 
mice express similar numbers of CD4+CD25+Foxp3+ cells when analyzed 
by fl  ow cytometry using a Foxp3 staining kit as described in Materials and 
methods. Bars represent mean percentages of CD4+CD25+Foxp3+ cells 
from fi  ve individual 8-wk-old B cell–defi  cient (μ−/−) or WT mice. (C and D) 
Representative Foxp3 staining results for a B cell–defi  cient (C) or WT 
(D) mouse.JEM VOL. 203, February 20, 2006  355
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for the activation of autoreactive T cells (10, 11, 17–20), or 
that autoreactive T cells were activated in B cell–defi  cient 
mice but did not induce tissue damage (11, 36). Alard et al. 
(30) and Tung et al. (37) showed that T cells able to respond 
to an ovarian self-antigen were present in neonatal mice. 
Tolerance to the antigen developed in the fi  rst week of life in 
females, but males that did not express the antigen did not 
develop tolerance. We previously hypothesized that B cell–
defi  cient mice might not develop SAT if the antigen that 
  initiates activation of autoreactive T cells for SAT had to be 
presented by B cells. In the absence of B cells, presentation of 
antigen by other APCs might induce unresponsiveness so 
  autoreactive T cells would be unable to respond even if anti-
gen-presenting B cells were subsequently provided. To test 
this hypothesis, we used B cell–defi  cient mice to ask if SAT 
would develop if T reg cells were depleted. The results sug-
gest that T reg cells may be preferentially activated in SAT-
resistant B cell–defi  cient NOD.H-2h4 mice. When T reg 
cells are depleted using anti-CD25 mAb or by day 3 Tx, ef-
fector T cells are activated and B cell–defi  cient mice develop 
SAT (Tables I and IV). Similar mechanisms are apparently 
operative in mice with Ig nonsecreting B cells specifi  c for the 
NP hapten (Table II).
To our knowledge, these results are the fi  rst to demon-
strate that resistance of B cell–defi  cient mice to autoimmune 
diseases can be due to the activity of T reg cells. Consistent 
with our results, Olson et al. (38) recently showed that B cells 
expanding in mice developing intestinal infl  ammation in a 
mouse model of Crohn’s disease could block T reg cell activ-
ity, resulting in exacerbation of disease. B cells in their model 
expressed increased mRNA for GITR-L compared with 
B cells from control mice that did not block T reg cell activity. 
GITR-L, expressed by APCs including dendritic cells, B cells, 
and macrophages, interacts with GITR, a molecule expressed 
by both T reg and activated T eff  ector cells (38–42). When 
GITR is engaged with its ligand, suppression is presumably 
“off  ,” whereas when GITR and its ligand are not engaged, 
suppression is “on” (40). Our results could be explained if 
B cells in WT NOD.H-2h4 mice expressed more GITR-L 
(or another molecule able to interfere with T reg cell activity) 
than B cells from NP Tg mice or non–B cell APCs in NP 
Tg or B cell–defi  cient mice. Although further studies are 
needed to fully address this possibility, preliminary results 
  indicate that splenocytes from WT, B cell–defi  cient, and 
NP Tg mice express similar levels of GITR-L mRNA 
(not depicted).
Another unexpected and interesting observation in this 
study was that depletion of T reg cells in NP Tg mice re-
sulted in very severe SAT with many B220+ B cells in thy-
roids (Fig. 3). These results indicate that B cells can traffi   c 
to sites of infl  ammation even if they have no apparent speci-
fi  city for thyroid antigens and are unable to secrete autoanti-
bodies. The role played by presumably antigen-nonspecifi  c 
B cells in the thyroids of NP Tg mice is unknown, although 
they may be able to present thyroid antigens to eff  ector T 
cells in sites where the antigen is abundant, as in the thyroid. 
Antigen-nonspecifi  c B cells also migrate to the pancreas in 
NP Tg B cell–defi  cient nonobese diabetic (NOD) mice, but 
the incidence of diabetes was very low compared with that in 
WT NOD mice (43). In a model of autoimmune arthritis 
with a requirement for B cells for development of disease, B 
cells from NP Tg mice functioned as APCs for activation of 
T cells only if autoantigen was specifi  cally targeted to B cells 
to increase antigen uptake (20). This suggests that conjugat-
ing MTg, the putative autoantigen for SAT, to NP might re-
sult in increased uptake of MTg by NP-specifi  c B cells, and 
NP Tg mice might then develop SAT. Studies to address this 
possibility are in progress. In addition to the diff  erence in an-
tigen specifi  cities of the B cells in NP Tg and WT mice, mice 
lacking serum IgM reportedly have more marginal zone B 
cells and fewer follicular B cells (44), and diff  erences in B cell 
subsets could also infl  uence whether T reg or T eff  ector cells 
would be preferentially activated.
Several studies have shown that CD4+CD25+ T cells can 
regulate experimental autoimmune thyroiditis in mice (45–49). 
In some cases, T reg cells were presumably induced by MTg 
presented peripherally on particular subsets of dendritic cells 
(47, 48) or by MTg presented under tolerogenic conditions 
(45). In contrast, the T reg cells described here presumably 
belong to the class of “natural” T reg cells because their func-
tion is lost after day 3 Tx (21, 22). These natural T reg 
cells might be activated by Tg expressed in the thymus dur-
ing T cell development (50, 51). Further studies will be re-
quired to determine if T reg cells that inhibit SAT in B cell–
defi  cient and NP Tg mice are specifi  cally activated by MTg 
or another thyroid antigen, and whether they are activated 
in the thymus or in peripheral lymphoid organs (52).
MATERIALS AND METHODS
Mice. NOD.H-2h4 mice, originally provided by L. Wicker (University of 
Cambridge, Cambridge, UK), are I-E negative and express I-Ak, H-2Kk, 
and Dd on the NOD background (1–4). B cell–defi  cient NOD.H-2h4 mice 
were derived as described previously (5). NOD mice expressing Tg B cells 
specifi  c for the NP hapten and unable to secrete Ig (12, 43) were obtained 
from S. Wong (Yale University, New Haven, CT). They were crossed with 
B cell–defi  cient NOD.H-2h4 mice to generate NP Tg mice on the NOD.
H-2h4 B cell–defi  cient background. The mice are serum Ig negative and 
have normal numbers of peripheral B220+ B cells that express the NP trans-
gene (12, 20). All mice were bred and maintained under specifi  c pathogen-
free conditions in our animal facilities at the University of Missouri. All 
animal protocols were approved by the University of Missouri and the VA 
Animal Care and Use Committees. Both male and female mice were used, 
and mice were age- and sex-matched for each experiment. All mice received 
0.05% NaI in their drinking water beginning at 7–8 wk of age.
Antibody treatment, Tx, and experimental design. Mice were given 
3 weekly 0.5-mg injections of rat anti–mouse CD25 mAb PC61 (American 
Type Culture Collection [ATCC]) beginning in most experiments 10–11 d 
after birth (23). In some experiments, antibody treatments began later or 
mice were given rat anti–mouse IL-10 mAb JESS 2A5 (ATCC) as indicated 
in Results. Anti-CD25 and anti–IL-10 were purifi  ed from cell culture su-
pernatants using Protein G columns (Kierkegaard and Perry). At 8 wk of age, 
treated and control mice were given 0.05% NaI water and thyroids were re-
moved 8–9 wk later (1, 5). For some experiments, mice were thymecto-
mized 3 d after birth as described previously (29). In brief, 3-d-old mice 
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  removed by suction. Mice were given 0.05% NaI water at 8 wk of age, and 
thyroids were removed 8–9 wk later. At the time of thyroid removal, the 
thoracic cavity was carefully inspected and mice with obvious thymic rem-
nants were excluded from the experiments.
Assessment of thyroiditis. Thyroids were collected and one thyroid lobe 
from each mouse was fi  xed in formalin, sectioned, and stained with hema-
toxylin and eosin as described previously (1, 5). The other thyroid lobe 
from each mouse was snap frozen in liquid nitrogen and stored at −70°C 
for use in immunohistochemical staining. Thyroid histopathology was 
scored for the extent of thyroid follicle destruction using a scale of 0 to 5+ 
as described previously (1, 4, 5). All slides were coded and read by two 
  individuals, one of whom had no knowledge of the experimental groups. In 
brief, a score of 0 indicates a normal thyroid, and 0+ indicates a few infl  am-
matory cells infi  ltrating the thyroids and/or mild follicular changes. A 1+ 
severity score is defi  ned as an infi  ltrate of at least 125 cells in one or several 
foci, and a 2+ score represents 10–20 foci of cellular infi  ltration, each the 
size of several follicles, with destruction of up to one fourth of the gland. 
A 3+ score indicates that one fourth to one half of the thyroid follicles are 
destroyed or replaced by infi  ltrating infl  ammatory cells, whereas a 4+ score 
indicates that greater than one half of the gland is destroyed. A few thyroids 
had almost no remaining intact follicles, and these were given a score of 5+. 
As described previously (1), thyroid lesions in NOD.H-2h4 mice reach 
maximal severity 7–9 wk after mice are given NaI water beginning at 2 mo 
of age; lesions are chronic and remain relatively unchanged in severity for 
several months (1, 4).
Autoantibody determination. MTg-specifi  c autoantibodies were assessed 
by ELISA using serum from individual mice as described previously (1, 5).
Flow cytometry. Spleen cells or PBLs were analyzed for expression of 
CD4, CD8 and CD25 by fl  ow cytometry as described previously (5). FITC-
conjugated antibodies were obtained from Caltag Laboratories. PE-conju-
gated anti-CD25 was obtained from SouthernBiotech (7D4) or Caltag 
Laboratories (PC 61). Flow cytometry for Foxp3 was performed using sple-
nocytes from 8-wk-old NOD.H-2h4 WT or B cell–defi  cient mice   using 
a Foxp3 staining kit according to the manufacturer’s protocol (eBioscience). 
Antibodies used were FITC-conjugated anti-CD4 (Caltag Laboratories), 
PECy5-conjugated CD25 (eBioscience), and PE-conjugated Foxp3 
(eBioscience). Cells were analyzed using a FACScan (BD Biosciences).
Separation of CD4+CD25+ and CD4+CD25-depleted splenocytes. 
Spleen cells from 6–8-wk-old naive WT and B cell–defi  cient mice were 
separated into CD4+CD25+ and CD4+CD25-depleted populations as fol-
lows. Mice were given anti-CD8 mAb 3 d before use to deplete splenic 
CD8+ T cells. Spleen cells were depleted of most B cells and macrophages 
by passage over nylon wool columns. Nylon wool nonadherent WT cells 
typically expressed no detectable CD8+ T cells and <15% B cells, and cells 
from B cell–defi  cient mice were >90% CD4+ when analyzed by fl  ow 
  cytometry. CD4+CD25+ cells were positively selected by labeling with PE-
conjugated PC61 and separated into CD25+ and CD25-depleted populations 
using Easy Sep magnetic beads (StemCell Technologies Inc.). Cells recov-
ered in the CD25+ fraction comprised <10% of the total CD4+ T cells, and 
 85% were CD4+CD25+ as determined by fl  ow cytometry. The CD25-
depleted population comprised >90% of the CD4+ T cells and always had 
some residual CD25+CD4+ cells as determined by fl  ow cytometry. Cells 
were counted, pelleted, and snap frozen in liquid nitrogen at 2–4 × 106 cells 
per tube.
Quantitative PCR. RNA was isolated using TRIzol (Invitrogen) and 
cDNA was synthesized as described previously in detail (1). Quantitative 
PCR was performed using ABsolute QPCR SYBR Green ROX Mix (AB-
gene) in an ABI PRISM 7000 sequence detection system (Applied Biosys-
tems). A series of fi  ve standards with defi  ned values was included in each 
reaction and a standard curve was obtained to calculate the amount of gene 
amplifi  ed. A dissociation curve was generated to verify the amplifi  cation of 
a single product. The primer sequences for Foxp3 and the housekeeping 
gene HPRT were described previously (1, 53). The level of HPRT expres-
sion for each sample was used for data normalization.
Immunohistochemical staining. Immunohistochemical staining of fro-
zen thyroid sections was performed as described previously (4, 24) using the 
following primary antibodies: anti-CD4 (GK 1.5; ATCC), anti-CD8 (53.67; 
ATCC), anti-CD11b (CRL 1969; ATCC), or anti-B220 (Caltag Laborato-
ries). Biotinylated goat anti–rat IgG (Caltag Laboratories) was used as sec-
ondary antibody, and 0.3% hydrogen peroxide was used to block endogenous 
peroxidase. Sections were incubated with Vectastain Elite ABC kit (Vector 
Laboratories), and peroxidase activity was visualized using the Nova-Red 
substrate (Vector Laboratories). Slides were counterstained with hematoxy-
lin. Negative controls used IgG isotype controls as primary antibody, with 
the remaining steps performed as described above. These controls were 
  always negative.
Student’s t test. Statistical analysis was performed using an unpaired two-
tailed Student’s t test. A value of P < 0.05 was considered statistically 
signifi  cant.
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